Discontinued — last reported Q4 '22
Interest Income
United Therapeutics Interest Income decreased by 3.2% to $41.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.2%, from $51.10M to $41.80M. Over 4 years (FY 2021 to FY 2025), Interest Income shows an upward trend with a 84.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher interest income suggests a strong cash position or a favorable interest rate environment for the company's investments.
Detailed definition
Interest income is the revenue earned from cash deposits, marketable securities, and other interest-bearing investments....
Peer comparison
Varies based on cash management strategies; companies with large cash piles will report higher interest income than those with high debt.
interest_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.00M | $3.80M | $4.20M | $4.30M | $6.80M | $13.30M | $20.80M | $29.20M | $37.20M | $45.30M | $51.00M | $53.80M | $46.20M | $49.80M | $49.30M | $51.10M | $51.30M | $46.40M | $43.20M | $41.80M |
| QoQ Change | — | -5.0% | +10.5% | +2.4% | +58.1% | +95.6% | +56.4% | +40.4% | +27.4% | +21.8% | +12.6% | +5.5% | -14.1% | +7.8% | -1.0% | +3.7% | +0.4% | -9.6% | -6.9% | -3.2% |
| YoY Change | — | — | — | — | +70.0% | +250.0% | +395.2% | +579.1% | +447.1% | +240.6% | +145.2% | +84.2% | +24.2% | +9.9% | -3.3% | -5.0% | +11.0% | -6.8% | -12.4% | -18.2% |
Interest Income at Other Companies
Frequently Asked Questions
- What is United Therapeutics's interest income?
- United Therapeutics (UTHR) reported interest income of $41.80M in Q1 2026.
- How has United Therapeutics's interest income changed year-over-year?
- United Therapeutics's interest income decreased by 18.2% year-over-year, from $51.10M to $41.80M.
- What is the long-term trend for United Therapeutics's interest income?
- Over 4 years (2021 to 2025), United Therapeutics's interest income has grown at a 84.1% compound annual growth rate (CAGR), from $16.70M to $192.00M.
- What does interest income mean?
- The money earned from interest on cash holdings and investments.